"[People] had been developing Arabidopsis microarrays for a number of years, and these were some of the first papers that published high-quality data with real biological conclusions," says Chris Town ...
Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...
The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
The treatment involves inserting a tiny implant thinner than human hair under the retina. Patients then have to wear glasses ...
ObvioHealth, a global leader in digital clinical trial solutions, announced that it has signed a three-year agreement with Vaxxas, a clinical-stage biotechnology company pioneering a needle-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback